AP
Live price temporarily unavailable.
Price history
Apogee Therapeutics Inc (APGE) is a Health Care company. Latest news and coverage below.
IPO: July 14, 2023 · $17.00 offering · NASDAQ · View IPO details →
Recent News (8)
-
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?
-
AbbVie completes $10.9B Apogee Therapeutics acquisition AbbVie completes $10.9B Apogee Therapeutics acquisition grafa.com
-
AbbVie (ABBV) Stock: Breaking Down the $10.9B Apogee Therapeutics Acquisition AbbVie (ABBV) Stock: Breaking Down the $10.9B Apogee Therapeutics Acquisition Blockonomi
-
AbbVie Completes Acquisition of Apogee Therapeutics Acquisition deepens AbbVie's robust immunology pipeline with diverse assets targeting dermatologic, respiratory and other inflammatory and immunological diseases Apogee's lead asset, zumilokibart, is …
-
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
-
AbbVie (ABBV) Lowers Earnings Outlook Amid Apogee Therapeutics A AbbVie (ABBV) Lowers Earnings Outlook Amid Apogee Therapeutics A GuruFocus
-
AbbVie (ABBV) Lowers Earnings Outlook Amid Apogee Therapeutics A AbbVie (ABBV) Lowers Earnings Outlook Amid Apogee Therapeutics A GuruFocus
-
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International